SILK Profile
Silk Road Medical, Inc. operates as a medical device company in the United States, focusing on the innovative treatment of carotid artery disease through its proprietary transcarotid artery revascularization (TCAR) technology. Headquartered in Sunnyvale, California, the company was founded in 2007 with a mission to improve patient outcomes and reduce procedural risks associated with carotid artery disease, which is a major cause of stroke.
The company's flagship products include the ENROUTE Transcarotid Neuroprotection System, which allows for direct access to the common carotid artery and initiates temporary blood flow reversal to protect the brain during procedures. Additionally, the ENROUTE Transcarotid Stent System is a self-expanding, self-tapering stent designed to provide structural support to the artery and prevent restenosis. These products are complemented by the ENHANCE Transcarotid Peripheral Access Kit, which facilitates initial access to the carotid artery, and the ENROUTE 0.014 Guidewire, essential for navigating and crossing target lesions during interventions.
Silk Road Medical's TCAR procedure combines surgical principles with endovascular techniques, offering a less invasive alternative to traditional carotid endarterectomy. This approach minimizes the risk of complications such as cranial nerve injury and has demonstrated improved patient outcomes in clinical studies. The company's commitment to rigorous clinical research and innovation has established TCAR as a preferred method for treating patients with carotid artery disease, particularly those at high risk for adverse events with conventional surgery.
The company's products are widely adopted by vascular surgeons and interventionalists across the United States. Silk Road Medical continues to invest in research and development to expand its product offerings and improve existing technologies. By providing advanced tools and comprehensive training programs, the company supports healthcare professionals in delivering optimal care to patients. Silk Road Medical's strategic focus on education, innovation, and quality positions it as a leader in the treatment of carotid artery disease, driving its mission to reduce the global burden of stroke.
|
